Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board

Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board Joins Diversigen’s Scientific Advisory Board Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board PAUL, MN, January 25, 2021 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc.  (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor of Medicine, Section of  Infectious […]

Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study

ST. PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC). The study, titled: “Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in […]

Diversigen Inc. Selected by Nom NomTM as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services

PAUL, MN and OAKLAND, CA, May 22, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Nom NomTM, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will also serve as Nom Nom’s central lab […]

OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries

OraSure Technologies, Inc. announces that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service.   Investor Contact: Roberto Cuca Chief Financial Officer 610-882-1820 investorinfo@orasure.com Media Contact: […]

OraSure Technologies, Inc. Announces Purchase of Diversigen

Acquisition extends OraSure’s leadership position in the microbiome services industry BETHLEHEM, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today announced that it has entered into a definitive agreement to acquire the outstanding equity of Diversigen in an all-cash transaction. Diversigen […]